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Hans Emmanuel Enoch (1896 – 1991) was born in Hamburg, the son of a 
manufacturer of sera and vaccines. Upon his father’s death he took charge of the 
Hamburg Serum Werke. Following the rise of Hitler, he came to be pilloried in the 
Nazi press for allegedly having poisoned the population of Hamburg and was 
imprisoned for a time. He immigrated to England in 1935 where he had secured a 
position with the International Serum Company in Norwich. Following the outbreak of 
war he was interned as an enemy alien, eventually ending up in Canada. In 1941 he 
was permitted to return to England, but wartime conditions prevented him from 
continuing to manufacture sera.  At about this time penicillin was making the 
headlines, and coupled with accounts of its miraculous properties, was the news that 
all production was reserved exclusively for the armed forces. Enoch decided to meet 
the public clamour for penicillin by producing a crude version which he termed 
‘vivicillin.’ News of this spread globally, and he came to incur the disdain of Howard 
Florey for the attendant publicity. Notwithstanding this, vivicillin was to prove itself 
effective, and its use led to the saving of lives. 
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Early Life, Military Service and Career 
Hans Enoch was born on 5th August, 1896 in Hamburg. At first he attended the 
Wilhelm Gymnasium there but later, at the age of 13, was sent to the Gymnasium in 
Cuxhaven.  Following the award of his abitur in February 1915 he was called up for 
active service with the 5th Guards Field Artillery Regiment. In November of the same 
year his regiment left for the Eastern front where he was assigned to the telephone 
and observation service. This comprised having to establish and maintain an 
observation post in the foremost trench and connecting it with the battery position by 
means of a telephone wire. These lines were frequently destroyed through shelling, 
and under such circumstances it fell to Enoch to conduct repairs. To do this required 
having to crawl out into open country, usually at night time, but occasionally in 
daylight when he would come within sight of the enemy. During one expedition to 
repair telephone wires a comrade of Enoch’s was hit by gunfire. Enoch crawled over 
to him and dressed his wounds before returning to his own lines to request a 
stretcher party to recover him. He accompanied the stretcher bearers and 
successfully recovered the wounded man. For this feat Enoch received the Iron 
Cross. In May of that year Enoch himself came to be badly wounded by artillery fire 
and he narrowly avoided having his right leg amputated. Following his recovery he 
was transferred to a reserve unit of his regiment before being discharged from 
military service in June, 1918. It was then that he was awarded the Iron Cross, First 
Class, for service with his regiment.  
It is fitting to mention here that Hans Enoch’s obituary1 spoke of his having ‘led a 
charmed life.’ In addition to surviving the events described above, once on a flight 
from Frankfurt to Hamburg in 1928 the aeroplane he was on crashed shortly after 
take-off, breaking into two and catching fire; he escaped with only minor injuries.  
Having been discharged from military service, he had resolved to study Medicine 
and Chemistry at Heidelberg University. He passed his pre-medical examination in 
May, 1919 and then took the decision to undertake the clinical part of his medical 
studies in Hamburg, obtaining his MD in June, 1921. He then went on to receive 
specialised training in bacteriology under Professor Hans Much who had himself 
served as assistant to Emil von Behring. At the beginning of 1922 Enoch started 
working at the Paul Ehrlich Institute in Frankfurt where he was assigned to Professor 
Heinrich Hetsch who was in charge of the government’s procedures for testing sera 
and vaccines.  
In April 1922, shortly after the death of his father, Carl, Hans took charge of the 
running of the Ruete-Enoch Serum Laboratory which had been jointly established by 
his father and Adolf Ruete for the manufacture of sera and vaccines in 1894. The 
company was set up following the publication by Emil von Behring of a method for 
the production of diphtheria antitoxin serum, and for which he was subsequently 
awarded the Nobel Prize for Physiology or Medicine in 1901.  
Hüntelman2 has described the background in Germany leading to the imposition of 
strict regulations relating to the manufacture of diphtheria antitoxin serum to prevent 
sub-standard or even harmful products being dispensed to the public. State 
regulations came to be applied to all sera and vaccines. These involved securing 
batches of products with special seals and stencils to prevent their distribution until 
they had been assayed at approved institutes. Once they had met the required 
standards an official was dispatched to remove the seals and allow the serum to be 
dispensed into ampoules for sale.  These procedures came to be suspended during 
the First World War owing to a shortage of control officials. All of the equipment (i.e. 
stencils and pliers) used for the process described above were handed over to 
licensed producers for them to continue manufacture and dispensing during the 
period of hostilities.  
The Rise of the Nazis 
The following constitutes what Hans Enoch refers to as ‘the darkest chapter of [his] 
life.’3 In November, 1932 Professor Glage who was in charge of the state control of 
veterinary products enquired of Enoch whether it was the case that he himself had 
been conducting the sealing of the various products which his company had been 
manufacturing. Enoch responded that he had, and that this was in accordance with a 
licence to do so that had been issued to his father’s company. In fact in 1919 Carl 
Enoch had been awarded the Iron Cross for supplying the German army with sera 
and vaccines. He was advised by Glage to obtain a copy of the licence so that this 
could be verified. On applying to the Public Health Department for it they informed 
him that they had no record whatsoever of such a licence. 
It emerges that the instigator of the original enquiry was an employee of Enoch’s, 
one Paul Glück. Glück had started working at the company under Carl Enoch who 
dismissed him when he discovered that Glück had been stealing oats intended for 
the horses used to produce sera so that he could sell them on the black market. On 
assuming control of the company, Enoch reemployed him on the understanding that 
he would conduct himself properly. However, Enoch discovered him deliberately 
presenting laboratory mice to a cat in order to derive sadistic pleasure from the 
inevitable outcome of this act, and he was once again dismissed.  Glück had 
become a fanatical Nazi, and had sought revenge by approaching editors of Nazi 
newspapers.  
An article appeared in the Hamburger Tageblatt on 25th November, 1932 demanding 
Hans Enoch’s immediate arrest for forging the stencils used to seal ‘bad sera and 
vaccines’ which were subsequently sold, and which had caused numerous deaths 
both in Germany and in other countries. It was further alleged that he had sold 
contaminated meat from horses used to produce sera for human consumption and, 
in addition, that he had poisoned the water supply of Hamburg.  
An even more virulent denunciation of Enoch appeared on the front cover of Der 
Stürmer, bearing the headline ‘Dr Hans Enoch, the poison mixer of Hamburg’ (Figure 
1). Enoch served as a target for Julius Streicher, the editor of Der Stürmer, on two 
counts. Firstly he was a Jew, and secondly he belonged to the medical profession. 
Streicher was opposed to modern medicine and the head of one of Germany’s most 
prominent organic health movements.4 Moreover, serum production was, of course, 
centred on blood which would have evoked in Streicher’s mind connections to the 
long-standing blood libel accusation against the Jews. 
Following the appearance of these articles, two detectives appeared at the 
laboratory to arrest him. Enoch became highly agitated, and in his desperation broke 
a small glass vessel containing tetanus toxin receiving a cut to his hand from a shard 
of glass. Enoch assured the detectives that they were not in danger, and he was 
subsequently escorted to the police station. Once there he declared that he had tried 
to commit suicide and refused to disclose the nature of the toxin. Various attempts 
from friends of his to persuade him to reveal its identity were made but he steadfastly 
refused to do so. His worsening condition led to his being transferred to hospital. 
Further investigations at the scene of the incident led to the discovery of a label 
bearing the word ‘tetanus’ on one of the pieces of broken glass. Enoch was then 
given a massive dose of tetanus anti-toxin of his own manufacture.  His mother 
turned up at the hospital bearing with her a copy of the licence from the Public 
Health Department permitting his company to seal ampoules of sera which had been 
located at the premises of a pharmacist who had worked with the company during 
the war. However, the licence to conduct the testing etc. had been issued in 1917 for 
a period of 10 years, and therefore Enoch was technically in breach of the 
agreement. The existence of the licence essentially disproved the charge that he had 
forged seals and the case was dismissed but he continued to undergo harassment. 
Now the imputations against him centred on his continued sealing of sera after the 
expiry of the licence.  He was even again briefly re-arrested.  
In January 1934 the case against him was brought to court, the charge being that he 
had forged seals so that he could pass off sub-standard sera for sale.  Differences 
had been discovered between the type of seal which Enoch had used and the one 
that was currently being applied. In his diary Enoch reproaches himself for not 
having sought out the licence to acquaint himself with its provisions. He accepts that 
he had breached the terms regarding the date of expiry but asserts that the design of 
the seals had been changed by the control authorities since his father had been 
officially provided with the sealing equipment. Glück claimed that he had seen letters 
from the Charité Hospital in Berlin to the effect that deaths had resulted from the use 
of his sera. However, the medical superintendent at the Charité refuted these 
allegations.  As regards the quality of his sera, a number of professors, including 
Professor Hetsch, testified that the methods Enoch used were entirely sound and in 
keeping with officially approved methods.   
Notwithstanding these refutations, and given the prevailing climate of the times, 
Enoch was convicted for ‘sustained forgery of documents.’ He was sentenced to 7 
months imprisonment; the term having been decided upon because as an ex-
serviceman sentences of 6 months and below were automatically subject to an 
amnesty. Enoch describes the trial as ‘fair but the sentence as not.’ As he was not 
immediately imprisoned he was able to visit old colleagues at the Paul Ehrlich 
Institute who advised him to serve out his sentence and then to leave Germany. 
During his time in prison he came to be visited by a certain Major Delss who had 
informed him of an opportunity in England for him with the International Serum 
Company based in Norwich and formed by William Howes. Howes had originally 
trained as a veterinary surgeon but subsequently decided to establish a business for 
producing sera, vaccines and other pharmaceutical products for treating the 
diseases of animals.  
Arrival in England 
Following his release from prison, Enoch travelled to Norwich in November of 1934 
to pay a visit to Howes. He was put off both by the heavy fog which hung over the 
town and by the primitive state of the production facilities he saw at the company’s 
premises. In his mind he initially decided against joining them, but when he was 
apprised of the terms under which he was to be employed, which included a monthly 
salary of £40, the opportunity to purchase a significant portion of the company’s 
shares, the offer of a directorship in the company after 12 months and the provision 
of accommodation in Norwich, he accepted the position. Notwithstanding this it was 
with ‘a heavy heart’ that he decided to leave Hamburg for England. It was on March 
31st 1935 that he, along with his mother and his aunt arrived, in England. 
He quickly established himself in his new environment and took on the manufacture 
of a wide range of products including those which the company had previously had 
to source from abroad, and became in his own words his ‘own lab assistant and 
cleaner.’ He was prevented from producing sera because he was unable at that time 
to purchase the horses needed to do so. In addition to producing vaccines from 
standard cultures, Enoch commenced the production of autogenous vaccines, using 
bacteria isolated from samples sent to him by veterinary surgeons.  
He felt impeded in his endeavours by the fact that most of the laboratory supplies he 
depended on had to be obtained from London. One of the practices he instigated 
was that of promptly dispatching products on receipt of orders. He frequently took 
them to the railway station at Norwich himself - this included late at night and 
Sundays and Bank Holidays. The company’s reputation rose as a result and this led 
to an increased turnover.  Whilst in Enoch’s opinion the success the company was 
enjoying should have been welcomed by Howes, the latter began to feel that his 
position as Managing Director was at risk. Enoch learnt from the chief clerk that 
Howes had forbidden him from discussing the company’s finances with him. Enoch 
foresaw that his association with Howes was not destined to last for very much 
longer. Enoch started thinking about setting up a laboratory in London.  He 
eventually found a suitable property in Hendon that could provide both living quarters, 
laboratory space and stabling for horses. Critically, the property was within easy 
reach of the railway network on which the efficient despatch of products was critically 
reliant. It was on 1st July, 1937 that Enoch began production of sera in London.  
However, he did not break ties with Howes, and continued to supply the Norwich 
offices with various products. 
Internment  
Following the declaration of war with Germany, conditions for refugees in England 
steadily worsened. Enoch recounts how people with whom he had formed 
acquaintanceships would now turn their faces away if he encountered them in the 
street. Having installed two skylights in the roof of his property in Hendon, Enoch 
was visited by detectives from Scotland Yard investigating claims made by 
neighbours that he had been signalling to German planes during air-raids. On 
another occasion he had to appear before a tribunal to provide assurances that he 
posed no threat to the water supply by discharging pathogenic bacteria into the 
drains as part of his sera and vaccine manufacturing activities. Then in June 1940 he 
was taken to Hampstead Police Station in what was to mark the beginning of his 
time as an internee. He was first transferred to Kempton Park Racecourse and from 
there to the Isle of Man where, he writes, that he felt himself in ‘a mousetrap’ in view 
of what was widely felt to be the prospects of a Nazi invasion of the British Isles. 
However, he contrived to change places with a fellow inmate who was to be 
transferred to an internment camp on the outskirts of Quebec, Canada. He 
experienced many of the tensions that existed between Nazis and Jews, all of whom 
were at this stage classified as ‘enemy aliens’ and were interned together, and which 
have been notably recounted by Peter and Leni Gillman.5 There he was permitted to 
conduct prophylactic immunisations of fellow inmates. He was on one occasion 
summoned to appear before the Camp Commander regarding an outbreak of Malta 
fever that had broken out in Southern England among cattle that had received 
vaccines produced by him. He was also informed that a search of his laboratories 
had been undertaken by Scotland Yard but cultures of the causative agent of Malta 
fever, Brucella melitensis, had not been found, and the assumption was made that 
he had destroyed them to cover up the evidence. He was obviously able to convince 
his interrogators of his innocence, for he was treated to a meal in what he describes 
as an ‘elegant restaurant in town.’ Later in October 1940 a division was conducted of 
internees into two groups, ‘Gentiles’ and ‘non-Gentiles’ who were placed in separate 
camps. He ended up in a camp located in between Montreal and Sherbrooke.  With 
time and as a more informed understanding of the true status and circumstances of 
internees was formed, he came to be categorised as Category C – i.e. those aliens 
considered harmless. Enoch made an application to be allowed to be released on 
the basis of his work on the production of vaccines and sera, and was interviewed by 
officials from the Home Office. He secured support for his case from the Society for 
the Protection of Science and Learning in Cambridge, and it was on 28th February, 
1941 that he found himself back on British soil.     
Return to England & Manufacture of Vivicillin 
Of his time in Norwich Enoch wrote that he felt that ‘[his] work for human beings 
which was [his] true profession and [his] love had come to an end.’ His instincts were 
to resume the manufacture of sera for the treatment of human diseases. However, 
wartime conditions prevented him from doing so, as he found it impossible to 
purchase horses, or, indeed, even the fodder with which to feed them. But a 
fundamental change in the approach to treating diseases caused by pathogenic 
bacteria had occurred: the introduction of penicillin. News about penicillin first 
appeared in the press in 1942, and grew at an exponential rate throughout 1943. As 
a result of these reports penicillin began to take on in the mind of the public the 
status of a panacea, but coupled to this was the news that all production was to be 
reserved for the armed forces.6 It was at this point that Enoch decided to undertake 
its manufacture. He had received instructions on fungal cultivation from the 
distinguished mycologist, Hugo Plaut,7 and managed to obtain the Fleming strain of 
P. notatum. How he did so is not made clear, but he had had contacts with the 
National Collection of Type Cultures in Colindale as a result of his serum and 
vaccine manufacturing activities, and it may be assumed that he obtained the culture 
through his contacts there. He produced two different products. The first he termed 
‘vivicillin’ as it contained living hyphae of the fungus, and the second ‘pennotin.’ He 
provided these products to an acquaintance of his, Dr von Lustig-Lendva, a 
veterinary surgeon. Encouraging results were obtained in a variety of animals with 
vivicillin given parenterally and for pennotin applied topically.  
The Publicity Surrounding Vivicillin 
Following the encouraging results obtained with animals, Enoch’s instincts were to 
extend trials to humans. He approached Major Delss who recommended that he 
consult with a certain Dr Kurt Wallersteiner.  Wallersteiner proposed that they should 
jointly submit a manuscript on vivicillin to Nature, they did so and it duly appeared in 
print.8  
In late April, 1944 Enoch received a call from the Press Association informing him of 
the imminent appearance of newspaper reports on vivicillin. It emerged that 
Wallersteiner had supplied them with information about it and had described himself 
as its co-discoverer. Enoch tried to persuade his caller to withhold publication but 
was informed that it was too late to do so. He was therefore prepared for press 
coverage but not for ‘the tidal wave’ of publicity that was to follow. He awoke the 
following morning to queues of cars parked outside his house, from which teams of 
reporters and photographers emerged. Enoch was averse to publicity but states that 
Lustig-Lendva, who had turned up at his premises, revelled in it.  
It emerges that Howard Florey had been contacted by the press for his views on 
vivicillin. Florey’s attitude to the press was one of mistrust, and his avoidance of 
reporters was legendary.9 He described vivicillin as an ‘absolute racket’ and went on 
to state that ‘in the state of communications existing at present this story will be 
round the world.’10 In a letter to Professor Garrod, who held the post of City 
Bacteriologist for London Florey wrote that it reminded him of a scandal he 
encountered in Beirut where French technicians were selling ampoules of what they 
alleged was penicillin at £5 per ampoule.11 Florey was to be proved correct in his 
prediction of the extent of media coverage of news about vivicillin. In addition to 
accounts in the national presses were those that reached the most remote corners of 
primarily - but not exclusively - the English-speaking world through the medium of 
local newspapers.  Merely setting down a selection of American titles illustrates the 
point; Moorhead Daily News, Tucson Daily Citizen and the Naugatuck Daily News, 
the latter appearing between May 10th and 11th 1944. It is remarkable how in an age 
before the internet news about vivicillin came to be spread with such alacrity! The 
image shown in Figure 2 came to be reproduced in scores of newspaper articles.  
Lustig-Lendva went on to publish a paper on the results he had achieved in treating 
animals with vivicillin.12 Lustig-Lendva is the sole author but an acknowledgement of 
Enoch’s distaste concerning the ‘premature publicity given to Vivicillin …without his 
knowledge’ appears at the end of the article.  Amongst the animal cases mentioned 
in the article is that of a ‘Pathologist, aged 47’ who had contracted swine erysipelas: 
this was in fact Hans Enoch. The stories that came to appear in the press were that 
Enoch had made himself a ‘human guinea pig’13 by deliberately infecting himself with 
a culture of the causitive agent. The fact was that he had accidentally infected 
himself in the course of his work. His condition was completely cured by treatment 
with vivicillin. Also included in these reports was the case of a boy suffering from 
haemophilia and who had contracted peritonitis and lay dying in hospital but who 
was cured by vivicillin.  The surgeon who treated him, Dr Seager of the Wellhouse 
Hopsital in Barnet, issued a statement that whilst ‘encouraging results’ had been 
obtained with vivicillin it was not ‘a cure-all.’14 Despite these comments Enoch felt 
irritated that treatment outcomes were being reported in the national press rather 
than in medical journals. He had a notice printed in one such journal deploring the 
‘misleading statements’ that had appeared in the press.15 
At the General Penicillin Committee Meeting held in May 1944, it was reported that 
two members of the committee had visited Hans Enoch and that they had formed the 
opinion that it was ‘worthy of investigation.’16 Florey was absent from the meeting. 
Shortly after this meeting, trials of vivicillin were conducted at an undisclosed military 
hospital.17 None of the dozen cases treated showed any amelioration. It emerges 
that the vivicillin was supplied not by Enoch but by a company called the Watford 
Chemical Co. which had been recently established by Wallersteiner. Whether the 
material was sub-standard or had deteriorated in transit it is not possible to establish. 
However, these outcomes are in complete contrast to the treatment of scores of 
cases treated by some half dozen doctors, whose identities were coded on the 
grounds of wartime security, and published in a booklet, presumably compiled by 
Enoch, in which the vast majority of those treated showed improvement18.  
Wallersteiner is variously referred to in the diaries both as ‘a friend’ and as ‘a kind of 
genius but most erratic and unreliable.’ In fact, long after the war he came to be 
convicted for various fraudulent activities. They subsequently had a falling out after 
which Wallersteiner produced a competitive product which he called ‘hypholin’ and 
which came to be referred to in the press  and as ‘a sort of chemical cousin’ of 
penicillin.19  It should be pointed out that whilst Wallersteiner did posses credible 
academic credentials, having studied Natural Sciences at Fitzwilliam House (now 
Fitzwilliam College), Cambridge and had even published work on counteracting 
sulphonamide inhibition,20 on the basis of post war revelations about him it seems 
likely that he was primarily driven by a desire for publicity coupled with the prospects 
of financial gain.  
The Scientific Basis for the Efficacy of Vivicillin 
A number of articles were published by respected researchers immediately after the 
war showing that impure penicillin was more potent than the purified material. It was 
concluded that the purification methods then in use resulted either in the removal or 
destruction of unknown compounds whose actions potentiated that of penicillin.21 It 
is possible that vivicillin which was an unpurified preparation retained some of these 
compounds which led to its efficacy. More recent studies have revealed that a class 
of polysaccharide known as β-glucans present in the cell wall of fungi offers 
protection against pathogenic bacteria22. The presence of fungal hyphae along with 
penicillin might therefore have acted as an ‘adjuvant’ to the antibiotic – a field of 
research in which there is keen interest in today owing to the low rate at which new 
antibiotic classes are being discovered.  
Pennotin was made with two spoonfulls of tea per pint of medium – a practice which 
Enoch had picked up from Hugo Plaut. Interestingly, the polyphenolics present in tea 
have subsequently been shown to have antimicrobial properties.23  
 
Appraisal of Life and Work  
 
Hans Enoch had been raised in an environment that centred on curing diseases and 
saving lives. That this instinct was passed down to him from his father is attested to 
by his saving the life of a comrade wounded in battle, and taking over the production 
of sera when his father passed away. His experiences at the hands of the Nazi press 
and what was to follow it must surely have left deep psychological scars on Enoch, 
and must have created within him a deep and life-long aversion to any form of 
publicity. That this is so is borne out by notices repudiating the publicity given to 
vivicillin that he had printed in journal articles. However, the same cannot be said of 
those with whom he became professionally associated.  
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Figure Captions 
Figure 1. The front page of Der Stürmer, December 1932. 
Figure 2. Hans Enoch engaged in the manufacture of vivicillin. (Image courtesy of 
Charles Enoch). 
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